Jan. 9, 2015 -- Two leading Ebola vaccines seem safe and clinical trials with healthy volunteers in West Africa will begin soon, according to the World Health Organization.
It says there is now enough data to show that the two most advanced Ebola vaccines have an "acceptable safety profile," the Associated Press reported.
One vaccine is made by GlaxoSmithKline and the other licensed by Merck and NewLink. Several other Ebola vaccines are being developed in the United States and elsewhere.
"(T)he cupboard (for Ebola vaccines) is filling up rapidly," Dr. Marie-Paule Kieny, who leads WHO's Ebola vaccine efforts, said at a media briefing Friday, the AP reported.